secwatch.observer — SEC 8-K summary
======================================

Issuer:     FibroBiologics, Inc. (FBLG)
CIK:        0001958777
Form:       8-K
Filed at:   2026-05-01T23:59:59+00:00
Accession:  0001193125-26-201376
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

FibroBiologics enters $6.15M ATM offering with H.C. Wainwright
--------------------------------------------------------------

- Up to $6.15M of common stock may be sold via at-the-market offering with H.C. Wainwright.
- H.C. Wainwright receives 3.0% commission on gross proceeds plus $100K legal reimbursement.
- Net proceeds used for working capital and general corporate purposes.
- Shares will be sold under existing S-3 shelf (Reg. No. 333-284663).
- Company not obligated to sell any shares; no assurance on price or timing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1958777/000119312526201376/0001193125-26-201376-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1958777/000119312526201376/fblg-20260501.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-201376

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer